A simple needle-stick may replace the scalpel for diagnosing men considered at risk for prostate cancer, Johns Hopkins doctors say.

They developed a blood test which monitors a blood protein recently identified at Johns Hopkins, early prostate cancer antigen-2. The test may change the way men are screened for prostate cancer ? a disease that kills tens of thousands each year.